tiprankstipranks
Trending News
More News >
Willow Biosciences (TSE:ATLE)
:ATLE

Willow Biosciences Inc (ATLE) Stock Statistics & Valuation Metrics

Compare
37 Followers

Total Valuation

Willow Biosciences Inc has a market cap or net worth of C$88.06M. The enterprise value is ―.
Market CapC$88.06M
Enterprise Value

Share Statistics

Willow Biosciences Inc has 352,222,660 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding352,222,660
Owned by Insiders
Owned by Institutions

Financial Efficiency

Willow Biosciences Inc’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee
Profits Per Employee
Employee Count19
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Willow Biosciences Inc is ―. Willow Biosciences Inc’s PEG ratio is ―.
PE Ratio
PS Ratio0.00
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, Willow Biosciences Inc had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue
Gross Profit
Operating Income
Pretax Income
Net Income
EBITDA
Earnings Per Share (EPS)

Cash Flow

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow
Free Cash Flow
Free Cash Flow per Share

Dividends & Yields

Willow Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.64
52-Week Price Change-58.33%
50-Day Moving Average0.16
200-Day Moving Average0.30
Relative Strength Index (RSI)56.96
Average Volume (3m)105.37K

Important Dates

Willow Biosciences Inc upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Willow Biosciences Inc as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Willow Biosciences Inc has paid ― in taxes.
Income Tax
Effective Tax Rate

Enterprise Valuation

Willow Biosciences Inc EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Willow Biosciences Inc has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities
Total Debt
Net Cash
Net Cash Per Share
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Willow Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast571.23%
EPS Growth Forecast64.25%

Scores

Smart Score2
AI Score46
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis